Rapid clearance of erythrodermic psoriasis with apremilast.

about

Rapid clearance of erythrodermic psoriasis with apremilast.

Item

http://www.wikidata.org/entity/Q49245883

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Rapid clearance of erythrodermic psoriasis with apremilast.

@en

Rapid clearance of erythrodermic psoriasis with apremilast.

@nl

type

Item

label

Rapid clearance of erythrodermic psoriasis with apremilast.

@en

Rapid clearance of erythrodermic psoriasis with apremilast.

@nl

prefLabel

Rapid clearance of erythrodermic psoriasis with apremilast.

@en

Rapid clearance of erythrodermic psoriasis with apremilast.

@nl

P1476

Rapid clearance of erythrodermic psoriasis with apremilast.

@en

P2093

Dimitrios Rigopoulos

http://www.w3.org/2001/XMLSchema#string

Evangelia Papadavid

http://www.w3.org/2001/XMLSchema#string

Georgios Kokkalis

http://www.w3.org/2001/XMLSchema#string

Georgios Polyderas

http://www.w3.org/2001/XMLSchema#string

Konstantinos Theodoropoulos

http://www.w3.org/2001/XMLSchema#string

P2860

Selective Phosphodiesterase Inhibitors for Psoriasis: Focus on Apremilast

Erythrodermic Psoriasis Treated with Apremilast.

Treatment of erythrodermic psoriasis: from the medical board of the National Psoriasis Foundation.

The efficacy and safety of apremilast, etanercept and placebo in patients with moderate-to-severe plaque psoriasis: 52-week results from a phase IIIb, randomized, placebo-controlled trial (LIBERATE)

Apremilast, an oral phosphodiesterase 4 (PDE4) inhibitor, in patients with moderate to severe plaque psoriasis: Results of a phase III, randomized, controlled trial (Efficacy and Safety Trial Evaluating the Effects of Apremilast in Psoriasis [ESTEEM

Apremilast mechanism of action and application to psoriasis and psoriatic arthritis

P304

29-31

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

case report

P356

10.3315/JDCR.2017.1246

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29367871

http://www.w3.org/2001/XMLSchema#string

P932

5776028

http://www.w3.org/2001/XMLSchema#string